Walker & Dunlop, Inc.
Business
Walker & Dunlop, Inc. is a leading U.S. commercial real estate services, finance, and technology company that originates, sells, services, and manages commercial real estate loans and related services. It offers multifamily lending through Agency and HUD programs, debt brokerage, property sales brokerage, appraisal and valuation services, housing market research, investment management, and affordable housing services including LIHTC syndication and development, supported by proprietary technology like Apprise. The company reports three segments: Capital Markets, Servicing & Asset Management, and Corporate. It serves owners, developers, institutional investors, Agencies, life insurers, banks, and correspondent originators across the United States via national brokerage, lending, servicing, investment management, and technology channels.
Summary from filing dated 2025-02-25
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenues | 1,234 | 1,132 | 1,054 | 1,259 | 1,259 | |
| Personnel | 648 | 559 | 514 | 607 | 603 | |
| Amortization and depreciation | 239 | 238 | 227 | 235 | 210 | |
| Provision (benefit) for credit losses | 10 | 11 | −10 | −12 | −13 | |
| Interest expense on corporate debt | 65 | 70 | 68 | 34 | 8 | |
| Goodwill impairment | 0 | 33 | 62 | — | — | |
| Fair value adjustments to contingent consideration liabilities | −8 | −50 | −63 | −14 | 7 | |
| Indemnified and repurchased loan expenses (NOTE 5) | 41 | 11 | — | — | — | |
| Asset impairments and other expenses (NOTE 17) | 37 | 1 | −607,000 | — | — | |
| Other operating expenses | 125 | 129 | 118 | 143 | 92 | |
| Total expenses | 1,155 | 1,001 | 916 | 994 | 907 | |
| Income before taxes | 79 | 132 | 138 | 265 | 352 | |
| Income tax expense | 22 | 31 | 35 | 56 | 86 | |
| Net income before noncontrolling interests and temporary equity holders | 57 | 101 | 103 | 209 | 266 | |
| Less: net income (loss) from noncontrolling interests | −99,000 | −7 | −4 | — | — | |
| Less: net income (loss) attributable to temporary equity holders | 837,000 | — | — | — | — | |
| Walker & Dunlop net income | 56 | 108 | 107 | 214 | 266 | |
| Other comprehensive income (loss), net of tax | 1 | 1 | 1 | — | — | |
| Walker & Dunlop comprehensive income | 58 | 109 | 108 | 210 | 266 | |
| Basic earnings per share (NOTE 11) | 1.65 | 3.19 | 3.2 | 6.43 | 8.27 | |
| Diluted earnings per share (NOTE 11) | 1.64 | 3.19 | 3.18 | 6.36 | 8.15 | |
| Basic weighted-average shares outstanding | 33 | 33 | 33 | 32 | 31 | |
| Diluted weighted-average shares outstanding | 33 | 33 | 33 | 33 | 32 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 299 | 279 | 329 | 226 | 306 | |
| Restricted cash | 23 | 25 | 21 | 18 | 43 | |
| Pledged securities, at fair value | 225 | 207 | 184 | 157 | 149 | |
| Loans held for sale, at fair value | 1,436 | 781 | 595 | 396 | 1,812 | |
| Mortgage servicing rights | 808 | 852 | 907 | 975 | 954 | |
| Goodwill | 869 | 869 | 902 | 960 | 699 | |
| Other intangible assets | 142 | 157 | 182 | 199 | 184 | |
| Receivables, net | 419 | 336 | 234 | 202 | 212 | |
| Committed investments in tax credit equity | 241 | 313 | 154 | 254 | 177 | |
| Other assets | 597 | 563 | 544 | 658 | 402 | |
| Total assets | 5,059 | 4,382 | 4,052 | 4,045 | 5,206 | |
| Warehouse notes payable | 1,420 | 782 | — | — | — | |
| Corporate notes payable | 829 | 768 | 773 | 704 | 740 | |
| Allowance for risk-sharing obligations | 38 | 28 | 32 | 44 | 63 | |
| Deferred tax liabilities, net | 237 | 241 | 245 | 243 | 225 | |
| Commitments to fund investments in tax credit equity | 220 | 275 | 140 | 239 | 163 | |
| Other liabilities | 570 | 528 | 519 | 560 | 495 | |
| Total liabilities | 3,314 | 2,622 | 2,306 | 2,329 | 3,628 | |
| Profit interests of a wholly owned subsidiary subject to possible redemption | −1 | — | — | — | — | |
| Preferred stock (authorized 50,000 shares; none issued) | — | — | — | — | — | |
| Common stock ($0.01 par value; authorized 200,000 shares; issued and outstanding 33,389 shares as of December 31, 2025 and 33,194 shares as of December 31, 2024) | 334,000 | 332,000 | 329,000 | 323,000 | 320,000 | |
| "Additional paid-in capital (""APIC"")" | 450 | 429 | 425 | 413 | 393 | |
| "Accumulated other comprehensive income (loss) (""AOCI"")" | 2 | 586,000 | −479,000 | −2 | 3 | |
| Retained earnings | 1,282 | 1,318 | 1,298 | 1,278 | 1,154 | |
| Total stockholders' equity | 1,735 | 1,748 | 1,724 | 1,689 | 1,550 | |
| Noncontrolling interests | 12 | 12 | 22 | 27 | 28 | |
| Total permanent equity | 1,747 | 1,760 | 1,746 | 1,717 | 1,578 | |
| Commitments and contingencies (NOTES 2 and 12) | — | — | — | — | — | |
| Total liabilities, temporary equity, and permanent equity | 5,059 | 4,382 | 4,052 | 4,045 | 5,206 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Gains attributable to the fair value of future servicing rights, net of guaranty obligation | −180 | −154 | −142 | −192 | −287 | |
| Change in the fair value of premiums and origination fees (NOTE 2) | 2 | 3 | −2 | 14 | 19 | |
| Stock compensation-equity and liability classified | 27 | 27 | 28 | 34 | 37 | |
| Indemnified and repurchased loans expenses - loan repurchase losses (Note 5) | 20 | — | — | — | — | |
| Deferred tax expense (benefit) | −6 | −3 | 1 | 18 | 34 | |
| Cash paid to settle risk-sharing obligations | — | — | −2 | −5 | — | |
| Impairment of real estate held for investment and equity method investment | 19 | 721,000 | 5 | — | — | |
| Originations of loans held for sale | −17,179 | −11,803 | −11,380 | −17,952 | −17,811 | |
| Proceeds from transfers of loans held for sale | 16,345 | 11,780 | 11,200 | 19,325 | 18,432 | |
| Other operating activities, net | 8 | 5 | 776,000 | 2 | 6 | |
| Receivables, net | −83 | −69 | −35 | 45 | −43 | |
| Other assets | 29 | −44 | −10 | −70 | −27 | |
| Other liabilities | 37 | 53 | 17 | −16 | 41 | |
| Net cash provided by (used in) operating activities | −664 | 129 | −518,000 | 1,583 | 870 | |
| Capital expenditures | −16 | −13 | −16 | −22 | −9 | |
| Capital invested in equity-method investments | −27 | −19 | −25 | −26 | −33 | |
| "Purchases of pledged available-for-sale (""AFS"") securities" | −47 | −51 | −13 | −61 | −32 | |
| Proceeds from prepayment and sale of pledged AFS securities | 27 | 10 | 11 | 14 | 45 | |
| Originations and repurchase of loans held for investment | −24 | −38 | — | −54 | −558 | |
| Principal collected on loans held for investment | — | 56 | 161 | 122 | 649 | |
| Other investing activities, net | 10 | 18 | 9 | 8 | — | |
| Net cash provided by (used in) investing activities | −77 | −38 | 127 | −134 | −378 | |
| Borrowings (repayments) of warehouse notes payable, net | 825 | 34 | 190 | −1,371 | −636 | |
| Repayments of interim warehouse notes payable | — | −26 | −120 | −64 | −228 | |
| Repayments of corporate notes payable | −332 | −8 | −122 | −37 | −295 | |
| Borrowings of corporate notes payable | 399 | — | 196 | — | 599 | |
| Repurchase of common stock | −10 | −12 | −21 | −42 | −19 | |
| Cash dividends paid | −92 | −89 | −85 | −80 | −64 | |
| Payment of contingent consideration | −12 | −34 | −26 | −21 | — | |
| Purchase of noncontrolling interests | — | −18 | −3 | −3 | — | |
| Debt issuance costs | −16 | −2 | −6 | −3 | −13 | |
| Other financing activities, net | −3 | 653,000 | 185,000 | −5 | — | |
| Net cash provided by (used in) financing activities | 758 | −155 | 7 | −1,584 | −458 | |
| Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents (NOTE 2) | 16 | −64 | 133 | −135 | 35 | |
| Cash paid to third parties for interest | 107 | 105 | 114 | 77 | 38 | |
| Cash paid for income taxes, net of cash refunds received | 23 | 32 | 31 | 59 | 43 |